האיחוד האירופי - שוודית - EMA (European Medicines Agency)

accord healthcare s.l.u. - tigecyklin - soft tissue infections; intraabdominal infections; bacterial infections; skin diseases, infectious - antibakteriella medel för systemiskt bruk, - tygecycline accord är indicerat hos vuxna och barn från åtta års ålder år för behandling av följande infektioner (se avsnitt 4. 4 och 5. 1):komplicerade infektioner i hud och mjukdelar (cssti), med undantag av diabetiska foten infektioner (se avsnitt 4. 4)komplicerade intraabdominella infektioner (ciai)tygecycline accord bör endast användas i situationer där andra alternativa antibiotika är inte lämpliga (se avsnitt 4. 4, 4. 8 och 5. hänsyn bör tas till officiella riktlinjer för lämplig användning av antibakteriella medel.

האיחוד האירופי - שוודית - EMA (European Medicines Agency)

accord healthcare s.l.u. - doxorubicin hydrochloride, liposomal - ovarian neoplasms; sarcoma, kaposi; multiple myeloma - doxorubicin - zolsketil pegylated liposomal is a medicine used to treat the following types of cancer in adults:• breast cancer that has spread to other parts of the body in patients at risk of heart problems. zolsketil pegylated liposomal is used on its own for this disease;• advanced ovarian cancer in women whose previous treatment including a platinum-based cancer medicine has stopped working;• multiple myeloma (a cancer of the white blood cells in the bone marrow), in patients with progressive disease who have received at least one other treatment in the past and have already had, or are unsuitable for, a bone marrow transplantation. zolsketil pegylated liposomal is used in combination with bortezomib (another cancer medicine);• kaposi’s sarcoma in patients with aids who have a very damaged immune system. kaposi’s sarcoma is a cancer that causes abnormal tissue to grow under the skin, on moist body surfaces or on internal organs. zolsketil pegylated liposomal contains the active substance doxorubicin and is a ‘hybrid medicine’. this means that it is similar to a ‘reference medicine’ containing the same active substance called adriamycin. however, in zolsketil pegylated liposomal the active substance is enclosed in tiny fatty spheres called liposomes, whereas this is not the case for adriamycin.

האיחוד האירופי - שוודית - EMA (European Medicines Agency)

accord healthcare s.l.u. - teriparatid - osteoporos - calciumhomeostas - sondelbay is indicated in adults. behandling av osteoporos hos postmenopausala kvinnor och hos män med ökad risk för fraktur. in postmenopausal women, a significant reduction in the incidence of vertebral and non-vertebral fractures but not hip fractures have been demonstrated. behandling av osteoporos i samband med ihållande systemisk glukokortikoid behandlingen för kvinnor och män med ökad risk för fraktur.

האיחוד האירופי - שוודית - EMA (European Medicines Agency)

accord healthcare s.l.u. - plerixafor - multiple myeloma; hematopoietic stem cell transplantation - immunstimulatorer, - adult patientsplerixafor accord is indicated in combination with granulocyte-colony stimulating factor (g-csf) to enhance mobilisation of haematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in adult patients with lymphoma or multiple myeloma whose cells mobilise poorly (see section 4. paediatric patients (1 to less than 18 years)plerixafor accord is indicated in combination with g-csf to enhance mobilisation of haematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in children with lymphoma or solid malignant tumours, either:- pre-emptively, when circulating stem cell count on the predicted day of collection after adequate mobilization with g-csf (with or without chemotherapy) is expected to be insufficient with regards to desired hematopoietic stem cells yield, or- who previously failed to collect sufficient haematopoietic stem cells (see section 4.

שוודיה - שוודית - Läkemedelsverket (Medical Products Agency)

norbrook laboratories limited - omeprazol - oral pasta - 370 mg/g - omeprazol 370 mg aktiv substans - omeprazol - häst

שוודיה - שוודית - Läkemedelsverket (Medical Products Agency)

stada arzneimittel ag - hydroklortiazid; lisinoprildihydrat - tablett - 10 mg/12,5 mg - hydroklortiazid 12,5 mg aktiv substans; lisinoprildihydrat 10,89 mg aktiv substans; mannitol hjälpämne - lisinopril och diuretika

שוודיה - שוודית - Läkemedelsverket (Medical Products Agency)

ebb medical ab - hydroklortiazid; lisinoprildihydrat - tablett - 10 mg/12,5 mg - lisinoprildihydrat 10,89 mg aktiv substans; hydroklortiazid 12,5 mg aktiv substans; mannitol hjälpämne

שוודיה - שוודית - Läkemedelsverket (Medical Products Agency)

amarox pharma b.v - omeprazol - enterokapsel, hård - 10 mg - sockersfärer hjälpämne; omeprazol 10 mg aktiv substans; propylenglykol hjälpämne - omeprazol

שוודיה - שוודית - Läkemedelsverket (Medical Products Agency)

amarox pharma b.v - omeprazol - enterokapsel, hård - 20 mg - propylenglykol hjälpämne; sockersfärer hjälpämne; omeprazol 20 mg aktiv substans - omeprazol

שוודיה - שוודית - Läkemedelsverket (Medical Products Agency)

amarox pharma b.v - omeprazol - enterokapsel, hård - 40 mg - propylenglykol hjälpämne; sockersfärer hjälpämne; omeprazol 40 mg aktiv substans - omeprazol